Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
J S M Peiris, C M Chu, V C C Cheng, K S Chan, I F N Hung, L L M Poon, K I Law, B S F Tang, T Y W Hon, C S Chan, K H Chan, J S C Ng, B J Zheng, W L Ng, R W M Lai, Y Guan, K Y Yuen, HKU/UCH SARS Study Group, J S M Peiris, C M Chu, V C C Cheng, K S Chan, I F N Hung, L L M Poon, K I Law, B S F Tang, T Y W Hon, C S Chan, K H Chan, J S C Ng, B J Zheng, W L Ng, R W M Lai, Y Guan, K Y Yuen, HKU/UCH SARS Study Group
Abstract
Background: We investigated the temporal progression of the clinical, radiological, and virological changes in a community outbreak of severe acute respiratory syndrome (SARS).
Methods: We followed up 75 patients for 3 weeks managed with a standard treatment protocol of ribavirin and corticosteroids, and assessed the pattern of clinical disease, viral load, risk factors for poor clinical outcome, and the usefulness of virological diagnostic methods.
Findings: Fever and pneumonia initially improved but 64 (85%) patients developed recurrent fever after a mean of 8.9 (SD 3.1) days, 55 (73%) had watery diarrhoea after 7.5 (2.3) days, 60 (80%) had radiological worsening after 7.4 (2.2) days, and respiratory symptoms worsened in 34 (45%) after 8.6 (3.0) days. In 34 (45%) patients, improvement of initial pulmonary lesions was associated with appearance of new radiological lesions at other sites. Nine (12%) patients developed spontaneous pneumomediastinum and 15 (20%) developed acute respiratory distress syndrome (ARDS) in week 3. Quantitative reverse-transcriptase (RT) PCR of nasopharyngeal aspirates in 14 patients (four with ARDS) showed peak viral load at day 10, and at day 15 a load lower than at admission. Age and chronic hepatitis B virus infection treated with lamivudine were independent significant risk factors for progression to ARDS (p=0.001). SARS-associated coronavirus in faeces was seen on RT-PCR in 65 (97%) of 67 patients at day 14. The mean time to seroconversion was 20 days.
Interpretation: The consistent clinical progression, shifting radiological infiltrates, and an inverted V viral-load profile suggest that worsening in week 2 is unrelated to uncontrolled viral replication but may be related to immunopathological damage.
Figures
References
- Severe Acute Respiratory Syndrome (SARS) multi-country outbreak—update 34. (accessed May 5, 2003).
- Centers for Disease Control and Prevention SARS coronavirus sequencing. (accessed May 5, 2003).
- Peiris JSM, Lai ST, Poon LLM. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325.
- Ksiazek TG, Erdman D, Goldsmith CS. A novel coronavirus associated with severe acute respiratory syndrome. (accessed at May 5, 2003).
- Poutanen SM, Low DE, Henry B. Identification of severe acute respiratory syndrome in Canada. (accessed May 5, 2003).
- Lee N, Hui D, Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. (accessed May 5, 2003).
- Tsang KW, Ho PL, Ooi GC. A cluster of cases of severe acute respiratory syndrome in Hong Kong. (accessed May 5, 2003).
- Atypical pneumonia. (accessed May 5, 2003).
- Ho W. Guideline on management of severe acute respiratory syndrome (SARS) Lancet. 2003;361:1313–1315.
- HA guidelines on severe acute respiratory syndrome. (accessed May 5, 2003).
- Bernard GR, Artigas A, Brigham KL. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824.
- Knaus WA, Draper EA, Wagner DP. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829.
- Poon LLM, Wong OK, Luk W. Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS) (accessed May 5, 2003).
- Majeski EI, Harley RA, Bellum SC. Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome. Am J Respir Cell Mol Biol. 2003;28:208–217.
- Ning Q, Brown D, Parodo J. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol. 1998;160:3487–3493.
- Turner RB, Felton A, Kosak K. Prevention of experimental coronavirus colds with intranasal alpha-2b interferon. J Infect Dis. 1986;154:443–447.
- Ollif JF, Williams MP. Radiological appearances of cytomegalovirus infections. Clin Radiol. 1989;40:463–467.
- Tutor JD, Montgomery VL, Eid NS. A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema. Pediatr Pulmonol. 1995;19:393–395.
Source: PubMed